As previously mentioned, the investigation of PAD4 inhibitors extends beyond sepsis and infectious diseases, showing promising results in other conditions such as rheumatoid arthritis [87], Kawasaki disease [88], ulcerative colitis [89], and cancers [90]. Here, PADI4 is linked to Sepsis.